Helixmith

Seoul, KR
Find alternatives to Helixmith for Plasmid →
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
59.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (3) ○ EMA GMP ○ MHRA GMP

Quick Facts: Helixmith

Signal Score
59.0/100 (as of 2026-10-29)
Quality Compliance
Assessment pending
Headquarters
Seoul, KR
Modalities
Plasmid, AAV
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Helixmith

Hybrid developer + CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesPlasmid, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Seoul, KR
Modalities: Plasmid, AAV
Capacity assessment: 58.0/100
Sites: Seoul, KR
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals3 articles (not scored)
1 manufacturing site: Seoul, KR
Modalities: Plasmid, AAV
Capacity assessment: 58.0/100

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Nov 20, 2026

Company Signals 3 articles

Company announcements, not verified evidence. They do not change any score.
general 2026-04-23
[Medical & Bio Briefs] Helixmith Submits Clinical Trial Protocol for Gene Therapy Engensis to US FDA, and More - 동아사이언스
[Medical & Bio Briefs] Helixmith Submits Clinical Trial Protocol for Gene Therapy Engensis to US FDA, and More  동아사이언스
general 2026-03-20
Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals - Barchart
Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals  Barchart
general 2026-03-20
Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals - Barchart
Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals  Barchart.com

Frequently Asked Questions About Helixmith

What is Helixmith's CDMO Signal Score?
Helixmith has a Signal Score of 59/100, based on quality, operations, financial stability, and capacity data.
Evaluating Helixmith for a manufacturing program?
Use the free AI matchmaker to compare Helixmith against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Plasmid CDMOs → AAV CDMOs →

Similar CDMOs

Pharmaron
San Diego, CA · Shaoxing, China, Liverpool, UK, Ningbo China
Signal Score: 86.9
AAV, Lentiviral, Plasmid, mAb, Antibody, Recombinant Protein, Biosimilars
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 82.9
AAV, Lentiviral, Plasmid, mRNA
Ascend Advanced Therapies
Rockville, MD · Alachua, FL · Munich, DE
Signal Score: 78.1
AAV, Lentiviral, Plasmid
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 77.6
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid, Small Molecule API, Oral Solid Dose, Sterile Fill-Finish

Compare Helixmith with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Helixmith
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.